SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lauren B. Malave, Patricia A. Broderick, Caffeine's Attenuation of Cocaine-Induced Dopamine Release by Inhibition of Adenosine, Journal of Caffeine Research, 2014, 4, 2, 35

    CrossRef

  2. 2
    Casey E. O’Neill, Benjamin D. Hobson, Sophia C. Levis, Ryan K. Bachtell, Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A1 and A2A receptors during extinction training in rats, Psychopharmacology, 2014, 231, 16, 3179

    CrossRef

  3. 3
    Sylvain Dubroqua, Benjamin K. Yee, Philipp Singer, Sensorimotor gating is disrupted by acute but not chronic systemic exposure to caffeine in mice, Psychopharmacology, 2014, 231, 21, 4087

    CrossRef

  4. 4
    Pablo Pandolfo, Nuno J. Machado, Attila Köfalvi, Reinaldo N. Takahashi, Rodrigo A. Cunha, Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder, European Neuropsychopharmacology, 2013, 23, 4, 317

    CrossRef

  5. 5
    Steven E. Meredith, Laura M. Juliano, John R. Hughes, Roland R. Griffiths, Caffeine Use Disorder: A Comprehensive Review and Research Agenda, Journal of Caffeine Research, 2013, 3, 3, 114

    CrossRef

  6. 6
    Cássia Sallaberry, Fernanda Nunes, Marcelo S. Costa, Gabriela T. Fioreze, Ana Paula Ardais, Paulo Henrique S. Botton, Bruno Klaudat, Thomás Forte, Diogo O. Souza, Elaine Elisabetsky, Lisiane O. Porciúncula, Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats, Neuropharmacology, 2013, 64, 153

    CrossRef

  7. 7
    Megan L.T. Hilbert, Christina E. May, William C. Griffin, Conditioned reinforcement and locomotor activating effects of caffeine and ethanol combinations in mice, Pharmacology Biochemistry and Behavior, 2013, 110, 168

    CrossRef

  8. 8
    Lucia Frau, Nicola Simola, Micaela Morelli, Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs, Journal of Caffeine Research, 2013, 3, 2, 79

    CrossRef

  9. 9
    Philipp Singer, Chuchu Zhang, Detlev Boison, Benjamin K. Yee, Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning, Pharmacology Biochemistry and Behavior, 2013, 104, 80

    CrossRef

  10. 10
    Rosa Luisa Potenza, Monica Armida, Antonella Ferrante, Antonella Pèzzola, Alessandra Matteucci, Maria Puopolo, Patrizia Popoli, Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis, Journal of Neuroscience Research, 2013, 91, 4
  11. 11
    Sarah Fliegel, Ines Brand, Rainer Spanagel, Hamid R Noori, Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis, In Silico Pharmacology, 2013, 1, 1, 7

    CrossRef

  12. 12
    Tharine Dal-Cim, Fabiana K. Ludka, Wagner C. Martins, Charlise Reginato, Esther Parada, Javier Egea, Manuela G. López, Carla I. Tasca, Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions, Journal of Neurochemistry, 2013, 126, 4
  13. 13
    Sergi Ferré, Marco Orrú, Xavier Guitart, Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission, Journal of Caffeine Research, 2013, 3, 2, 72

    CrossRef

  14. 14
    Marco Orrú, Xavier Guitart, Marzena Karcz-Kubicha, Marcello Solinas, Zuzana Justinova, Sandeep Kumar Barodia, Janaina Zanoveli, Antoni Cortes, Carme Lluis, Vicent Casado, F. Gerard Moeller, Sergi Ferré, Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans, Neuropharmacology, 2013, 67, 476

    CrossRef

  15. 15
    Stefania Vinci, Liliana Spina, Rosanna Longoni, Elio Acquas, Tea in Health and Disease Prevention, 2013,

    CrossRef

  16. 16
    Alan L. Harvey, Louise C. Young, Edgar Kornisiuk, Marina Snitcofsky, Natalia Colettis, Carlos Blanco, Diana Jerusalinsky, Andrew G. Jamieson, Richard C. Hartley, Trevor W. Stone, A novel dihydro-pyrazolo(3,4d)(1,2,4)triazolo(1,5a)pyrimidin-4-one (AJ23) is an antagonist at adenosine A1 receptors and enhances consolidation of step-down avoidance, Behavioural Brain Research, 2012, 234, 2, 184

    CrossRef

  17. 17
    Masahiro Mishina, Yuichi Kimura, Mika Naganawa, Kenji Ishii, Keiichi Oda, Muneyuki Sakata, Jun Toyohara, Shiro Kobayashi, Yasuo Katayama, Kiichi Ishiwata, Differential effects of age on human striatal adenosine A1 and A2A receptors, Synapse, 2012, 66, 9
  18. 18
    S González, C Rangel-Barajas, M Peper, R Lorenzo, E Moreno, F Ciruela, J Borycz, J Ortiz, C Lluís, R Franco, P J McCormick, N D Volkow, M Rubinstein, B Floran, S Ferré, Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain, Molecular Psychiatry, 2012, 17, 6, 650

    CrossRef

  19. 19
    Jeffrey H Mills, Leah M Alabanza, Deeqa A Mahamed, Margaret S Bynoe, Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis, Journal of Neuroinflammation, 2012, 9, 1, 193

    CrossRef

  20. 20
    Allison A. Feduccia, Yuanyuan Wang, Jeffrey A. Simms, Henry Y. Yi, Rui Li, Leonard Bjeldanes, Chuangxing Ye, Selena E. Bartlett, Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: Involvement of adenosine and dopamine receptors, Pharmacology Biochemistry and Behavior, 2012, 102, 2, 241

    CrossRef

  21. 21
    Susan E. Doyle, Florence J. Breslin, Jayson M. Rieger, Anthony Beauglehole, Wendy J. Lynch, Time and sex-dependent effects of an adenosine A2A/A1 receptor antagonist on motivation to self-administer cocaine in rats, Pharmacology Biochemistry and Behavior, 2012, 102, 2, 257

    CrossRef

  22. 22
    Gabor Perlaki, Gergely Orsi, Norbert Kovacs, Attila Schwarcz, Zilia Pap, Zsuzsanna Kalmar, Eniko Plozer, Arpad Csatho, Robert Gabriel, Samuel Komoly, Imre Janszky, József Janszky, Coffee consumption may influence hippocampal volume in young women, Brain Imaging and Behavior, 2011, 5, 4, 274

    CrossRef

  23. 23
    Jeffrey H. Mills, Leah Alabanza, Babette B. Weksler, Pierre-Olivier Couraud, Ignacio A. Romero, Margaret S. Bynoe, Human brain endothelial cells are responsive to adenosine receptor activation, Purinergic Signalling, 2011, 7, 2, 265

    CrossRef

  24. 24
    Liana Asatryan, Hyung W. Nam, Moonnoh R. Lee, Mahesh M. Thakkar, M. Saeed Dar, Daryl L. Davies, Doo-Sup Choi, Implication of the Purinergic System in Alcohol Use Disorders, Alcoholism: Clinical and Experimental Research, 2011, 35, 4
  25. 25
    Catherine J. Wei, Wei Li, Jiang-Fan Chen, Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2011, 1808, 5, 1358

    CrossRef

  26. You have free access to this content26
    Sergi Ferré, Carme Lluís, Zuzana Justinova, César Quiroz, Marco Orru, Gemma Navarro, Enric I Canela, Rafael Franco, Steven R Goldberg, Adenosine–cannabinoid receptor interactions. Implications for striatal function, British Journal of Pharmacology, 2010, 160, 3
  27. 27
    Å. Konradsson-Geuken, H.Q. Wu, C.R. Gash, K.S. Alexander, A. Campbell, Y. Sozeri, R. Pellicciari, R. Schwarcz, J.P. Bruno, Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry, Neuroscience, 2010, 169, 4, 1848

    CrossRef

  28. 28
    Elio Acquas, Stefania Vinci, Federico Ibba, Saturnino Spiga, Maria Antonietta De Luca, Gaetano Di Chiara, Role of dopamine D1 receptors in caffeine-mediated ERK phosphorylation in the rat brain, Synapse, 2010, 64, 5
  29. 29
    Hidemori Uchiyama, Akihisa Toda, Masumi Imoto, Satoko Nishimura, Hiroaki Kuroki, Shinji Soeda, Hiroshi Shimeno, Shigenori Watanabe, Reiko Eyanagi, The stimulatory effects of caffeine with oseltamivir (Tamiflu®) on light–dark behavior and open-field behavior in mice, Neuroscience Letters, 2010, 469, 2, 184

    CrossRef

  30. 30
    Xiao-Jun Zhang, Hong-Li Chen, Zhi Li, Hong-Qi Zhang, Hong-Xi Xu, Joseph J.Y. Sung, Zhao-Xiang Bian, Analgesic effect of paeoniflorin in rats with neonatal maternal separation-induced visceral hyperalgesia is mediated through adenosine A1 receptor by inhibiting the extracellular signal-regulated protein kinase (ERK) pathway, Pharmacology Biochemistry and Behavior, 2009, 94, 1, 88

    CrossRef

  31. 31
    J. Trevitt, K. Kawa, A. Jalali, C. Larsen, Differential effects of adenosine antagonists in two models of parkinsonian tremor, Pharmacology Biochemistry and Behavior, 2009, 94, 1, 24

    CrossRef

  32. 32
    Gabor Tuboly, Gabriella Kekesi, Edit Nagy, György Benedek, Gyöngyi Horvath, The antinociceptive interaction of anandamide and adenosine at the spinal level, Pharmacology Biochemistry and Behavior, 2009, 91, 3, 374

    CrossRef

  33. 33
    John J. O’Connor, Carmel O’Neill, A Role for Adenosine A1 Receptors in GABA and NMDA-Receptor Mediated Modulation of Dopamine Release: Studies Using Fast Cyclic Voltammetry, Sensors, 2008, 8, 9, 5516

    CrossRef

  34. 34
    Robyn M. Brown, Jennifer L. Short, Adenosine A2A receptors and their role in drug addiction, Journal of Pharmacy and Pharmacology, 2008, 60, 11
  35. 35
    Sergi Ferré, An update on the mechanisms of the psychostimulant effects of caffeine, Journal of Neurochemistry, 2008, 105, 4
  36. 36
    Mariangela Galluzzo, Anita Pintor, Antonella Pèzzola, Rosa Grieco, Franco Borsini, Patrizia Popoli, Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535, European Journal of Pharmacology, 2008, 579, 1-3, 149

    CrossRef

  37. 37
    J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, M. S. Bynoe, CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, 2008, 105, 27, 9325

    CrossRef

  38. 38
    Sergi Ferré, La cafeína en la enfermedad de Parkinson, Medicina Clínica, 2008, 131, 18, 710

    CrossRef

  39. 39
    Klaus Trier, Søren Munk Ribel-Madsen, Dongmei Cui, Søren Brøgger Christensen, Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study, Journal of Ocular Biology, Diseases, and Informatics, 2008, 1, 2-4, 85

    CrossRef

  40. 40
    S. Ferré, I. Diamond, S.R. Goldberg, L. Yao, S.M.O. Hourani, Z.L. Huang, Y. Urade, I. Kitchen, Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry, Progress in Neurobiology, 2007, 83, 5, 332

    CrossRef

  41. 41
    Gyongyi Horvath, Gabriella Kekesi, Gabor Tuboly, Gyorgy Benedek, Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level, Brain Research, 2007, 1155, 42

    CrossRef

  42. 42
    M. A. De Luca, V. Bassareo, A. Bauer, G. Di Chiara, Caffeine and accumbens shell dopamine, Journal of Neurochemistry, 2007, 103, 1
  43. 43
    Oscar P. Dall'Igna, Paulo Fett, Marcio W. Gomes, Diogo O. Souza, Rodrigo A. Cunha, Diogo R. Lara, Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice, Experimental Neurology, 2007, 203, 1, 241

    CrossRef

  44. 44
    Janusz Borycz, M. Fátima Pereira, Alessia Melani, Ricardo J. Rodrigues, Attila Köfalvi, Leigh Panlilio, Felicita Pedata, Steven R. Goldberg, Rodrigo A. Cunha, Sergi Ferré, Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments, Journal of Neurochemistry, 2007, 101, 2
  45. 45
    K.E. Hefner, R. Butler, A. Ravindra, Z. Ahmad, D. Molina, C.P. Turner, Dipyridamole Promotes Changes in Calbindin-D28k and Tyrosine Hydroxylase Expression in Neonatal Rats, Neonatology, 2007, 91, 4, 222

    CrossRef

  46. 46
    Mayumi Kitagawa, Hideki Houzen, Kunio Tashiro, Effects of caffeine on the freezing of gait in Parkinson's disease, Movement Disorders, 2007, 22, 5
  47. 47
    R. Franco, C. Lluis, E. I. Canela, J. Mallol, L. Agnati, V. Casadó, F. Ciruela, S. Ferré, K. Fuxe, Receptor–receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins, Journal of Neural Transmission, 2007, 114, 1, 93

    CrossRef

  48. 48
    Eduardo S. Ghisolfi, Alice Schuch, Ivo M. Strimitzer, Gustavo Luersen, Fabíola F. Martins, Fernanda L.P. Ramos, Jefferson Becker, Diogo R. Lara, Caffeine modulates P50 auditory sensory gating in healthy subjects, European Neuropsychopharmacology, 2006, 16, 3, 204

    CrossRef

  49. 49
    Gyongyi Horvath, Gabriella Kekesi, Interaction of endogenous ligands mediating antinociception, Brain Research Reviews, 2006, 52, 1, 69

    CrossRef

  50. 50
    Diogo R. Lara, Oscar P. Dall'Igna, Eduardo S. Ghisolfi, Miriam G. Brunstein, Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2006, 30, 4, 617

    CrossRef

  51. 51
    João M.N. Duarte, Catarina R. Oliveira, António F. Ambrósio, Rodrigo A. Cunha, Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats, Neurochemistry International, 2006, 48, 2, 144

    CrossRef

  52. 52
    Bruce Jenkins, Joseph Mandeville, Yin-Ching Chen, In Vivo MR Techniques in Drug Discovery and Development, 2006,

    CrossRef

  53. 53
    Elena Bastia, Yue-Hang Xu, Angela C Scibelli, Yuan-Ji Day, Joel Linden, Jiang-Fan Chen, Michael A Schwarzschild, A Crucial Role for Forebrain Adenosine A2A Receptors in Amphetamine Sensitization, Neuropsychopharmacology, 2005, 30, 5, 891

    CrossRef

  54. 54
    Katerina Antoniou, Zeta Papadopoulou-Daifoti, Thomas Hyphantis, Georgia Papathanasiou, Efstathios Bekris, Marios Marselos, Leigh Panlilio, Christa E. Müller, Steven R. Goldberg, Sergi Ferré, A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors, Psychopharmacology, 2005, 183, 2, 154

    CrossRef

  55. 55
    O. Cauli, M. Morelli, Caffeine and the dopaminergic system, Behavioural Pharmacology, 2005, 16, 2, 63

    CrossRef

  56. 56
    Marcello Solinas, Sergi Ferré, Katerina Antoniou, Davide Quarta, Zuzana Justinova, Jörg Hockemeyer, Lara A. Pappas, Pavan N. Segal, Carrie Wertheim, Christa E. Müller, Steven R. Goldberg, Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats, Psychopharmacology, 2005, 179, 3, 576

    CrossRef

  57. 57
    Y. Iris Chen, Ji-Kyung Choi, Bruce G. Jenkins, Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI, Synapse, 2005, 55, 2
  58. 58
    Meritxell Canals, Ester Angulo, Vicent Casadó, Enric I. Canela, Josefa Mallol, Francesc Viñals, William Staines, Barbro Tinner, Luigi Agnati, Kjell Fuxe, Sergi Ferré, Carmen Lluis, Rafael Franco, Molecular mechanisms involved in the adenosine A1 and A2A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary cultures, Journal of Neurochemistry, 2005, 92, 2
  59. 59
    Arash Rassoulpour, Hui-Qiu Wu, Sergi Ferrė, Robert Schwarcz, Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum, Journal of Neurochemistry, 2005, 93, 3
  60. 60
    Rodrigo A. Cunha, Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade, Purinergic Signalling, 2005, 1, 2, 111

    CrossRef

  61. 61
    Sandrine Vautrin, Yann Pelloux, Jean Costentin, Preference for caffeine appears earlier in non-anxious than in anxious mice, Neuroscience Letters, 2005, 386, 2, 94

    CrossRef

  62. 62
    Gabriella Kekesi, Gabriella Joo, Emese Csullog, Mihaly Peter-Szabo, Gyorgy Benedek, Gyongyi Horvath, Dose-independent antinociceptive interaction of endogenous ligands at the spinal level, Brain Research, 2004, 1029, 1, 93

    CrossRef